GSK-3 inhibitor 3

Catalog No. :
ACPNWF184
CAS No. :
2227279-84-5
Molecular Formula :
C23H15FN6O
Molecular Weight :
410.41

IUPAC Name:2-((4-cyanophenyl)amino)-N-(4-(4-fluorophenyl)pyridin-3-yl)pyrimidine-4-carboxamide

GSK-3 inhibitor 3 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$103.00Login to see priceIn stockInquiry
5mg98%$180.00Login to see priceIn stockInquiry
10mg98%$288.00Login to see priceIn stockInquiry
25mg98%$581.00Login to see priceIn stockInquiry
50mg98%$929.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameGSK-3 inhibitor 3
IUPAC Name2-((4-cyanophenyl)amino)-N-(4-(4-fluorophenyl)pyridin-3-yl)pyrimidine-4-carboxamide
Molecular FormulaC23H15FN6O
Molecular Weight410.41
SMILESO=C(C1=NC(NC2=CC=C(C#N)C=C2)=NC=C1)NC3=C(C4=CC=C(F)C=C4)C=CN=C3
InChI KeyQLWFPXXGZGCHFQ-UHFFFAOYSA-N
Synonym2-[(4-Cyanophenyl)amino]-N-[4-(4-fluorophenyl)-3-pyridinyl]-4-pyrimidinecarboxamide;GSK-3 inhibitor 3
CAS No.2227279-84-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACPNWF184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNWF184 route product structure diagram
    ACPNWF1842227279-84-5 In Stock
Inquiry

2. ACPNWF184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAIOY691 route compound structure diagram
    ACAIOY691873-74-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPNWF184 route product structure diagram
    ACPNWF1842227279-84-5 In Stock
Inquiry

Comments (0)